The best indicator for CAVA
We backtested 382 indicators across daily, weekly and hourly charts on real CAVA history. Here's what actually worked — risk-adjusted, out-of-sample, with costs.
Ehlers Reflex
On the daily chart, this is the strongest risk-adjusted edge we found for CAVA over ~3.0 years — beating buy-and-hold by 36.6% CAGR.
The winner on each chart
Every indicator, ranked
Ranked by Sharpe (risk-adjusted return). Hypothetical, fees included.
| # | Indicator | TF | CAGR | Sharpe | Max DD | Win | Trades | vs B&H |
|---|---|---|---|---|---|---|---|---|
| 1 | Ehlers Reflex ✓ | Daily | 60.5% | 1.34 | -28.0% | 65.2% | 23 | 36.6% |
| 2 | Balance of Power ✓ | Daily | 50.1% | 1.15 | -25.3% | 48.7% | 39 | 26.3% |
| 3 | Rate of Change ✓ | Daily | 48.2% | 1.13 | -35.3% | 52.5% | 40 | 24.4% |
| 4 | Chande Kroll Stop ✓ | Daily | 53.7% | 1.13 | -34.4% | 48.5% | 33 | 29.9% |
| 5 | Detrended Price Osc. ✓ | Weekly | 40.0% | 1.07 | -31.8% | 53.3% | 15 | 10.9% |
| 6 | Smoothed Heikin-Ashi ✓ | Daily | 45.2% | 1.08 | -32.1% | 42.6% | 47 | 21.3% |
| 7 | Stochastic Fast (5,3) ✓ | Weekly | 43.9% | 1.04 | -23.1% | 44.4% | 18 | 14.8% |
| 8 | EMA-10 Trend ✓ | Daily | 44.2% | 1.07 | -29.2% | 43.6% | 55 | 20.4% |
| 9 | Stochastic RSI ✓ | Daily | 30.1% | 1.07 | -37.0% | 65.2% | 23 | 6.3% |
| 10 | Pascal's Weighted MA ✓ | Daily | 38.2% | 1.07 | -23.2% | 52.8% | 36 | 14.4% |
| 11 | Disparity (10) ✓ | Daily | 44.2% | 1.07 | -29.2% | 43.6% | 55 | 20.4% |
| 12 | TRIX ✓ | Daily | 44.5% | 1.13 | -30.5% | 64.3% | 14 | 20.7% |
| 13 | MAMA / FAMA ✓ | Daily | 45.3% | 1.05 | -30.7% | 46.7% | 15 | 21.4% |
| 14 | RSI (25) ✓ | Daily | 41.4% | 1.05 | -35.2% | 52.6% | 19 | 17.6% |
✓ = held up out-of-sample. Hypothetical, costs included. See methodology.
For CAVA, Ehlers Reflex on the daily timeframe gave the best balance of return and risk in our test. It beat buy-and-hold — but remember: this is a hypothetical backtest of a standard rule, not a recommendation. Markets change. See the methodology and disclaimer.
More stock
Get the weekly edge report
The best-performing indicator per asset, what changed this week, and the honest caveats — straight to your inbox.